CN104397688A - 一种黄粉虫香菇高蛋白复合营养冲剂的生产方法 - Google Patents
一种黄粉虫香菇高蛋白复合营养冲剂的生产方法 Download PDFInfo
- Publication number
- CN104397688A CN104397688A CN201410635919.8A CN201410635919A CN104397688A CN 104397688 A CN104397688 A CN 104397688A CN 201410635919 A CN201410635919 A CN 201410635919A CN 104397688 A CN104397688 A CN 104397688A
- Authority
- CN
- China
- Prior art keywords
- millet
- mushroom
- yellow meal
- meal worm
- mealworm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- 239000008187 granular material Substances 0.000 title abstract description 4
- 240000000599 Lentinula edodes Species 0.000 title abstract 5
- 239000002131 composite material Substances 0.000 title abstract 2
- 244000062793 Sorghum vulgare Species 0.000 claims abstract description 29
- 235000019713 millet Nutrition 0.000 claims abstract description 29
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 39
- 241000254109 Tenebrio molitor Species 0.000 claims description 28
- 239000000843 powder Substances 0.000 claims description 15
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 241000382353 Pupa Species 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 4
- 230000008961 swelling Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 238000001125 extrusion Methods 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 10
- 230000036541 health Effects 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 235000013339 cereals Nutrition 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 208000001953 Hypotension Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 208000021822 hypotensive Diseases 0.000 description 4
- 230000001077 hypotensive effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 229920001491 Lentinan Polymers 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 229940115286 lentinan Drugs 0.000 description 2
- 230000000527 lymphocytic effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- LIEMBEWXEZJEEZ-INEUFUBQSA-N (2r,3r)-4-(6-aminopurin-9-yl)-2,3-dihydroxybutanoic acid Chemical compound NC1=NC=NC2=C1N=CN2C[C@@H](O)[C@@H](O)C(O)=O LIEMBEWXEZJEEZ-INEUFUBQSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- LIEMBEWXEZJEEZ-UHFFFAOYSA-N D-threo-Leutysin Natural products NC1=NC=NC2=C1N=CN2CC(O)C(O)C(O)=O LIEMBEWXEZJEEZ-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 235000007226 Setaria italica Nutrition 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000021393 food security Nutrition 0.000 description 1
- PUGBZUWUTZUUCP-ZRKHGVCBSA-N fungisterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CC[C@H](C)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 PUGBZUWUTZUUCP-ZRKHGVCBSA-N 0.000 description 1
- UHQOYWRQNBWEAM-NBPRQAIYSA-N fungisterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@@H]1CC[C@@H]2C3=C(CC[C@]12C)[C@@]4(C)CC[C@@H](O)C[C@H]4C=C3 UHQOYWRQNBWEAM-NBPRQAIYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011738 major mineral Substances 0.000 description 1
- 235000011963 major mineral Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P30/00—Shaping or working of foodstuffs characterised by the process or apparatus
- A23P30/30—Puffing or expanding
- A23P30/32—Puffing or expanding by pressure release, e.g. explosion puffing; by vacuum treatment
- A23P30/34—Puffing or expanding by pressure release, e.g. explosion puffing; by vacuum treatment by extrusion-expansion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Fruits And Vegetables (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种黄粉虫香菇高蛋白复合营养冲剂的生产方法,属于食品加工技术领域,具体涉及利用黄粉虫、香菇、小米生产老年营养食品的方法。为了提高老年人生活质量,达到食品安全、营养、功能保健的目的,本发明根据老年人生理特点采用以香菇、黄粉虫幼虫或者黄粉虫蛹、小米为原料生产老年人为主要消费群体的营养冲剂,解决了部分老年人食用黄粉虫有心理障碍问题,同时将香菇、小米、黄粉虫配伍组合,对提高老年人免疫力有益。
Description
技术领域
一种黄粉虫香菇高蛋白复合营养冲剂的生产方法,属于食品加工技术领域,具体涉及利用黄粉虫、香菇、小米生产老年营养食品的方法。
背景技术
黄粉虫所含高蛋白、游离氨基酸为哺乳动物的50-100倍、牛奶的11倍;脂溶性维生素a、d、e、k水溶性维生素b族的含量极为丰富,维生素b1是牛奶的15倍,维生素 b2是牛奶的1800倍,维生素b6是牛奶的52倍;另外,具有常量矿物质元素钙、钾、钠、镁等,微量矿物质元素铁、锌、铜、锰、钴、铬、硒、硼、碘等,营养素的含量均比牛奶和肉类丰富得多。黄粉虫脂肪含有丰富的不饱和脂肪酸,可提纯作为医用和化妆品用脂肪,能提高皮肤的抗皱功能,对皮肤病也有一定的治疗和缓解症状的作用,用黄粉虫为原料提取SOD作为美容养生产品原料,其抗衰老、防皱、美白、养颜效果也优于现有市场产品。黄粉虫特有的甲壳素和抗菌肽,有降低血压、提高免疫、活化细胞、预防癌症、降血脂、降血压、调节血糖、抗衰老,调节机体环境等多种功能作用,可用于医药产品和保健产品。另外,通过小鼠实验初步说明:黄粉虫具有一定的促进生长,益智,抗疲劳和抗组织缺氧的营养保健作用。杨兆芬等研究指出:黄粉虫幼虫干粉滤液具有较好的抗疲劳,延缓衰老和降低血脂及促进胆固醇代谢的功能,并能提高小鼠外周淋巴细饱转化和降低骨髓微核率;黄粉虫在活血强身、治疗消化系统疾病及康复治疗、老弱病人群的基本营养补充方面有着切实的辅助作用。在“合理膳食,均衡营养”的原则下,追求绿色昆虫、蛹菜现成为一种时尚,倍受人们青眯。老少皆宜的美味佳肴。黄粉虫口感好、风味独特、易于被消费者接受,可以烘烤、煎炸、加工成具有果仁味的蛋白饮品、精制蛋白粉等多种形式的食品。
香菇是具有高蛋白、低脂肪、多糖、多种氨基酸和多种维生素的菌类食物。香菇含有一种分子量为100万的抗肿瘤成分-----香菇多糖,含有降低血脂的成分-----香菇太生,香菇腺嘌呤和腺嘌呤的衍生物,香菇还含有抗病毒的成分------干扰素的诱发剂----双链核糖核酸,是不可多得的保健食品之一。香菇中含不饱和脂肪酸甚高,还含有大量的可转变为维生素D的麦角甾醇和菌甾醇,对于增强抗疾病和预防感冒及治疗有良好效果。经常食用对预防人体,特别是婴儿因缺乏维生素D而引起的血磷、血钙代谢障碍导致的佝偻病有益,可预防人体各种粘膜及皮肤炎病。香菇具有a、提高机体免疫功能:香菇多糖可提高小鼠腹腔巨噬细胞的吞噬功能,还可促进T淋巴细胞的产生,并提高T淋巴细胞的杀伤活性;b延缓衰老:香菇的水提取物对过氧化氢有清除作用,对体内的过氧化氢有一定的消除作用;c防癌抗癌:香菇菌盖部分含有双链结构的核糖核酸,进入人体后,会产生具有抗癌作用的干扰素;d降血压、降血脂、降胆固醇:香菇中含有嘌呤、胆碱、酪氨酸、氧化酶以及某些核酸物质,能起到降血压、降胆固醇、降血脂的作用,又可预防动脉硬化、肝硬化等疾病;香菇还对糖尿病、肺结核、传染性肝炎、神经炎等起治疗作用,又可用于消化不良、便秘等;香菇中所含香菇太生(lentysin)可预防血管硬化,可降低人的血压,从香菇中还分离出降血清胆固醇的成分(C8H1104N5,C9H1103N5)。香菇灰分中含有大量钾盐及其它矿质元素,被视为防止酸性食物中毒的理想食品;e提高人体免疫:美国农业部农业研究服务中心的农学家大卫·布鲁尔通过研究发现:香菇中含有一种高分子量多聚糖(HMWP),能够提高人体的免疫功能。大卫·布鲁尔是在阿肯色州的一个小农场里进行实验后发现香菇具有这种功效的。
谷子(学名:Setaria italica):属禾本科的一种植物。古称稷、粟,亦称粱。一年生草本;秆粗壮、分蘖少,狭长披针形叶片,有明显的中脉和小脉,具有细毛;穗状圆锥花序;穗长20~30厘米;小穗成簇聚生在三级支梗上,小穗基本有刺毛。每穗结实数百至上千粒,子实极小,径约0.1cm,谷穗一般成熟后金黄色,卵圆形籽实,粒小多为黄色。去皮后俗称小米蛋白质、维生素B2、该种是中国北方人民的主要粮食之一,谷粒的营养价值很高,含丰富的蛋白质和脂肪和维生素(据中央卫生研究院的分析,含蛋白质9.7%,脂肪1.7%,碳水化合物77%,而且在每100克小米中,含有胡萝卜素0.12毫克,维生素B1 0.66毫克和维生素B2 0.09毫克,烟酸、钙、铁等。适宜老人孩子等身体虚弱的人滋补。同时常吃小米还能降血压、防治消化不良、补血健脑、安眠等功效。还能减轻皱纹、色斑、色素沉积,有美容的作用。小米(谷子脱壳得到)气味:咸,微寒,无毒;主治:可以养肾气,除脾胃中热,利小便,治痢疾。磨成粉可以解毒,止霍乱。做粥食用可以开胃补虚。《本草纲目》记载:“养肾气,去脾胃中热,益气。陈者:苦,寒。治胃热消渴,利小便。”
将香菇、黄粉虫、小米组配伍,让三者营养功效充分发挥,采用一种安全、功能保健为一体的加工方法,目前尚未见报道。
发明内容
为了提高老年人生活质量,达到食品安全、营养、功能保健的目的,本发明根据老年人生理特点采用以香菇、黄粉虫幼虫或者黄粉虫蛹、小米为原料生产老年人为主要消费群体的营养冲剂,解决了部分老年人食用黄粉虫有心理障碍问题,同时将香菇、小米、黄粉虫配伍组合,对提高老年人免疫力有益。
具体实施
1) 将干香菇除杂、粉碎得到香菇粉待用;
2) 将小米除杂,得到干净的小米待用;
3) 按照重量比即黄粉虫幼虫干虫或黄粉虫干蛹:香菇粉:小米=1:1:5
4) 将1)步骤得到的香菇粉与2)步骤得到的小米分别按照3)步骤重量比称取香菇粉、小米定量混匀得到香菇小米混合物;
5) 将4)步骤得到的香菇小米混合物挤压膨化、粗粉碎得到膨化粉;
6) 按照3)步骤比例称取黄粉虫幼虫干虫或黄粉虫干蛹与4)步骤得到的膨化粉混合并粉碎,加入适量食盐,经杀菌包装得到本方法的黄粉虫香菇高蛋白复合营养冲剂。
Claims (1)
1.一种黄粉虫香菇高蛋白复合营养冲剂的生产方法,其特征在于该冲剂由干制的黄粉虫幼虫或虫蛹与香菇粉、小米共同配伍而成,具体按照如下生产方法得到:
1) 将干香菇除杂、粉碎得到香菇粉待用;
2) 将小米除杂,得到干净的小米待用;
3) 按照重量比即黄粉虫幼虫干虫或黄粉虫干蛹:香菇粉:小米=1:1:5
4) 将1)步骤得到的香菇粉与2)步骤得到的小米分别按照3)步骤重量比称取香菇粉、小米定量混匀得到香菇小米混合物;
5) 将4)步骤得到的香菇小米混合物挤压膨化、粗粉碎得到膨化粉;
6) 按照3)步骤比例称取黄粉虫幼虫干虫或黄粉虫干蛹与4)步骤得到的膨化粉混合并粉碎,加入适量食盐,经杀菌包装得到本方法的黄粉虫香菇高蛋白复合营养冲剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410635919.8A CN104397688B (zh) | 2014-11-13 | 2014-11-13 | 一种黄粉虫香菇高蛋白复合营养冲剂的生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410635919.8A CN104397688B (zh) | 2014-11-13 | 2014-11-13 | 一种黄粉虫香菇高蛋白复合营养冲剂的生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104397688A true CN104397688A (zh) | 2015-03-11 |
CN104397688B CN104397688B (zh) | 2016-08-31 |
Family
ID=52635410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410635919.8A Expired - Fee Related CN104397688B (zh) | 2014-11-13 | 2014-11-13 | 一种黄粉虫香菇高蛋白复合营养冲剂的生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104397688B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104782817A (zh) * | 2015-04-29 | 2015-07-22 | 高国强 | 一种亚麻(胡麻)香菇茶饮的生产方法 |
CN104814477A (zh) * | 2015-05-18 | 2015-08-05 | 合肥市好旺养殖科技有限公司 | 一种提高抵抗力汉虾粉 |
CN104824648A (zh) * | 2015-05-18 | 2015-08-12 | 合肥市好旺养殖科技有限公司 | 一种降血压保健蛋白粉 |
CN104920952A (zh) * | 2015-05-18 | 2015-09-23 | 合肥市好旺养殖科技有限公司 | 一种健康汉虾粉营养米粉 |
CN115515436A (zh) * | 2020-04-23 | 2022-12-23 | Cj第一制糖株式会社 | 包含双叉犀金龟幼虫提取物的肠运动改善组合物 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1110902A (zh) * | 1995-01-23 | 1995-11-01 | 郭巍杰 | 黄龙戏金蝉及加工方法 |
CN1312035A (zh) * | 2000-11-03 | 2001-09-12 | 周福孟 | 一种黄粉虫的加工方法及其用途 |
CN1545938A (zh) * | 2003-12-10 | 2004-11-17 | 王立新 | 一种面包虫食品的加工方法 |
CN1726818A (zh) * | 2005-07-26 | 2006-02-01 | 李政 | 一种黄粉虫食品及其制备方法 |
CN101223935A (zh) * | 2008-01-25 | 2008-07-23 | 张志友 | 用黄粉虫为原料的火腿肠及其加工方法 |
-
2014
- 2014-11-13 CN CN201410635919.8A patent/CN104397688B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1110902A (zh) * | 1995-01-23 | 1995-11-01 | 郭巍杰 | 黄龙戏金蝉及加工方法 |
CN1312035A (zh) * | 2000-11-03 | 2001-09-12 | 周福孟 | 一种黄粉虫的加工方法及其用途 |
CN1545938A (zh) * | 2003-12-10 | 2004-11-17 | 王立新 | 一种面包虫食品的加工方法 |
CN1726818A (zh) * | 2005-07-26 | 2006-02-01 | 李政 | 一种黄粉虫食品及其制备方法 |
CN101223935A (zh) * | 2008-01-25 | 2008-07-23 | 张志友 | 用黄粉虫为原料的火腿肠及其加工方法 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104782817A (zh) * | 2015-04-29 | 2015-07-22 | 高国强 | 一种亚麻(胡麻)香菇茶饮的生产方法 |
CN104814477A (zh) * | 2015-05-18 | 2015-08-05 | 合肥市好旺养殖科技有限公司 | 一种提高抵抗力汉虾粉 |
CN104824648A (zh) * | 2015-05-18 | 2015-08-12 | 合肥市好旺养殖科技有限公司 | 一种降血压保健蛋白粉 |
CN104920952A (zh) * | 2015-05-18 | 2015-09-23 | 合肥市好旺养殖科技有限公司 | 一种健康汉虾粉营养米粉 |
CN115515436A (zh) * | 2020-04-23 | 2022-12-23 | Cj第一制糖株式会社 | 包含双叉犀金龟幼虫提取物的肠运动改善组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN104397688B (zh) | 2016-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103999996A (zh) | 一种保健板栗及其制备方法 | |
CN104397688A (zh) | 一种黄粉虫香菇高蛋白复合营养冲剂的生产方法 | |
CN104687061A (zh) | 一种健康养生冰粉及其制备方法和一种冰粉粉的制备方法 | |
CN105495414A (zh) | 一种高丽红参芝麻抗衰老功能食品的制备方法 | |
CN105533415A (zh) | 一种高丽红参小麦胚芽抗氧化功能食品的制备方法 | |
KR20150040392A (ko) | 스테비아 음료원액제조방법 | |
CN106360698A (zh) | 一种降三高的辣木保健品及其制备方法 | |
CN108991078A (zh) | 一种防控富贵病的桑叶食品及其制备方法 | |
KR20130133946A (ko) | 한약재를 포함하는 된장 및 그의 제조방법 | |
CN105124077A (zh) | 一种百香果番茄袋茶 | |
CN102018158A (zh) | 一种芦荟果酱 | |
CN103798434A (zh) | 保健袋泡茶及其制备方法 | |
KR101808406B1 (ko) | 강황, 미강을 이용한 건강기능식품의 제조방법 | |
CN109043325A (zh) | 一种食用复合菌粉 | |
KR20190118720A (ko) | 사철쑥을 주성분으로 하는 기능성 및 친환경성 돼지사료용 보조제와 그 제조방법, 그리고 이를 이용한 돼지사육방법 및 그 돈육 | |
KR102480311B1 (ko) | 체질 맞춤형의 학습 능력 증진용 건강 기능성 식품 조성물 제조방법 | |
CN103652923A (zh) | 一种虫草含片的制备方法 | |
CN104206580B (zh) | 一种莞香花叶茶饮料及其制作工艺 | |
CN103719850A (zh) | 一种滋养调理组合物 | |
CN101347257B (zh) | 一种保健饮料 | |
KR20170024319A (ko) | 비파나무 발효 추출물과 전복의 한방 복합 열수 추출물이 혼합 조성된 건강 기능성 복합 추출물의 제조방법 | |
KR101773251B1 (ko) | 꾸지뽕 나무 발효 추출물과 전복의 한방 복합 열수 추출물이 혼합 조성된 건강 기능성 복합 추출물의 제조방법 | |
CN102150833B (zh) | 一种养生食品及其制备方法 | |
CN103550333A (zh) | 一种开胃降血压组合物 | |
CN103981072B (zh) | 一种有黄粉虫制剂的祛风健脾保健酒的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160831 Termination date: 20161113 |